David Whitlock

Inventor & Co-Founder at AOBiome Therapeutics

David Whitlock is the Inventor and co-founder of AOBiome. His initial discovery that Ammonia Oxidizing Bacteria could be reintroduced to the human microbiome formed the scientific basis for AOBiome’s efforts. Mr. Whitlock holds both an MS and a BS in Chemical Engineering from MIT and is the author or co-author of several key patents in the field.



  • Inventor & Co-Founder

    Current role

View in org chart